铂-话题@MedSci

#铂#

382篇内容 | 6073人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1737603, encodeId=21031e3760396, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=J Gastroenterology：吉西他滨联合顺铂作为一线化疗的晚期胆道癌患者治疗结果的预测因子分析, objectType=article, longId=161798, objectId=7b44161e9849, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b44161e9849, replyNumber=0, likeNumber=48, createdTime=2019-08-22, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b44161e9849, moduleTitle=J Gastroenterology：吉西他滨联合顺铂作为一线化疗的晚期胆道癌患者治疗结果的预测因子分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b44161e9849)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737586, encodeId=140f1e37586ba, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=ANN ONCOL：直肠癌患者年龄对奥沙利铂有效性的影响, objectType=article, longId=147480, objectId=571f14e480c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=571f14e480c7, replyNumber=0, likeNumber=92, createdTime=2019-06-16, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=571f14e480c7, moduleTitle=ANN ONCOL：直肠癌患者年龄对奥沙利铂有效性的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=571f14e480c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737585, encodeId=e8711e3758590, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=ANN ONCOL：蛋白结合型紫杉醇联合卡铂或吉西他滨治疗转移性三阴性乳腺癌, objectType=article, longId=147408, objectId=1ea914e40885, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ea914e40885, replyNumber=0, likeNumber=80, createdTime=2019-04-02, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ea914e40885, moduleTitle=ANN ONCOL：蛋白结合型紫杉醇联合卡铂或吉西他滨治疗转移性三阴性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ea914e40885)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737568, encodeId=a5b61e37568cf, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=CLIN CANCER RES：新辅助卡铂和多西他赛治疗的三阴性乳腺癌患者的病理缓解情况, objectType=article, longId=136502, objectId=919713650250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=919713650250, replyNumber=0, likeNumber=64, createdTime=2018-09-10, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=919713650250, moduleTitle=CLIN CANCER RES：新辅助卡铂和多西他赛治疗的三阴性乳腺癌患者的病理缓解情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=919713650250)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737579, encodeId=ebaf1e375796c, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet Oncol：多西紫杉醇、顺铂和氟尿嘧啶联合化疗用于晚期肛门鳞状细胞癌, objectType=article, longId=142337, objectId=41ec14233e9b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41ec14233e9b, replyNumber=0, likeNumber=64, createdTime=2018-12-01, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41ec14233e9b, moduleTitle=Lancet Oncol：多西紫杉醇、顺铂和氟尿嘧啶联合化疗用于晚期肛门鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41ec14233e9b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737571, encodeId=2f781e37571b6, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JCO：新辅助吉西他滨联合顺铂治疗肌层浸润膀胱癌, objectType=article, longId=138009, objectId=d07b13800958, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d07b13800958, replyNumber=0, likeNumber=86, createdTime=2018-11-28, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d07b13800958, moduleTitle=JCO：新辅助吉西他滨联合顺铂治疗肌层浸润膀胱癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d07b13800958)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737591, encodeId=52671e3759101, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Clin Cancer Res：顺铂诱导毒性的遗传和可修饰风险因素分析, objectType=article, longId=151243, objectId=3ad015124313, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ad015124313, replyNumber=0, likeNumber=63, createdTime=2019-06-06, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ad015124313, moduleTitle=Clin Cancer Res：顺铂诱导毒性的遗传和可修饰风险因素分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ad015124313)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737566, encodeId=49a31e3756616, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JCO：卡铂-紫杉醇 vs 卡铂-紫杉醇-曲妥珠单抗治疗子宫浆液性癌, objectType=article, longId=133724, objectId=4a7d133e24be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a7d133e24be, replyNumber=0, likeNumber=72, createdTime=2018-04-08, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a7d133e24be, moduleTitle=JCO：卡铂-紫杉醇 vs 卡铂-紫杉醇-曲妥珠单抗治疗子宫浆液性癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a7d133e24be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737573, encodeId=2ef01e37573fc, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Sci Rep：肿瘤浸润性淋巴细胞对患有转移性尿路上皮癌且接受铂化疗患者的预后影响, objectType=article, longId=138562, objectId=74ad138562ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74ad138562ae, replyNumber=0, likeNumber=52, createdTime=2018-07-13, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74ad138562ae, moduleTitle=Sci Rep：肿瘤浸润性淋巴细胞对患有转移性尿路上皮癌且接受铂化疗患者的预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74ad138562ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737570, encodeId=9ee41e37570ca, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Nat Med：“靶向化疗”成为可能—卡铂用于治疗BRCA1/2突变及BRCAness表型三阴性乳腺癌的III期TNT研究, objectType=article, longId=137196, objectId=7db713e1967a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7db713e1967a, replyNumber=0, likeNumber=90, createdTime=2019-04-15, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7db713e1967a, moduleTitle=Nat Med：“靶向化疗”成为可能—卡铂用于治疗BRCA1/2突变及BRCAness表型三阴性乳腺癌的III期TNT研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7db713e1967a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737560, encodeId=5d211e3756079, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Acta Oncol：睾丸癌幸存者铂化疗前后听力损失研究, objectType=article, longId=130213, objectId=128f1302133b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=128f1302133b, replyNumber=0, likeNumber=68, createdTime=2018-12-31, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=128f1302133b, moduleTitle=Acta Oncol：睾丸癌幸存者铂化疗前后听力损失研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=128f1302133b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737589, encodeId=d8831e37589e1, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=J Gastroenterology：吉西他滨联合顺铂作为一线化疗的晚期胆道癌患者预后风险评估, objectType=article, longId=150952, objectId=32681509528a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32681509528a, replyNumber=0, likeNumber=62, createdTime=2018-10-15, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32681509528a, moduleTitle=J Gastroenterology：吉西他滨联合顺铂作为一线化疗的晚期胆道癌患者预后风险评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32681509528a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737588, encodeId=df051e375881f, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=BJC：S-1加顺铂联合同步放疗治疗局部晚期不可切除的非小细胞肺癌, objectType=article, longId=150145, objectId=086e15014582, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=086e15014582, replyNumber=0, likeNumber=71, createdTime=2019-03-03, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=086e15014582, moduleTitle=BJC：S-1加顺铂联合同步放疗治疗局部晚期不可切除的非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=086e15014582)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737578, encodeId=4df11e3757864, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=CLIN CANCER RES：AZD1775联合新辅助多西他赛和顺铂治疗头颈部鳞状细胞癌, objectType=article, longId=141953, objectId=6d9f14195367, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d9f14195367, replyNumber=0, likeNumber=67, createdTime=2019-03-06, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d9f14195367, moduleTitle=CLIN CANCER RES：AZD1775联合新辅助多西他赛和顺铂治疗头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d9f14195367)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737563, encodeId=de2e1e375632e, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet Oncol：卡波铂+ veliparib对三阴性乳腺癌高危患者新标准化疗效果的影响, objectType=article, longId=131089, objectId=56eb131089ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56eb131089ae, replyNumber=0, likeNumber=55, createdTime=2018-10-05, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56eb131089ae, moduleTitle=Lancet Oncol：卡波铂+ veliparib对三阴性乳腺癌高危患者新标准化疗效果的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56eb131089ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737553, encodeId=93e71e3755335, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Prostate Cancer P D：转移性前列腺癌中的铂敏感性分析, objectType=article, longId=125031, objectId=b5ec125031e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5ec125031e3, replyNumber=0, likeNumber=66, createdTime=2018-06-16, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5ec125031e3, moduleTitle=Prostate Cancer P D：转移性前列腺癌中的铂敏感性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5ec125031e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737567, encodeId=06ad1e37567da, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Int J Cancer：铂抵抗性卵巢癌模型中，FASN抑制剂对其产生的生长和代谢影响研究, objectType=article, longId=133903, objectId=01ce13390346, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01ce13390346, replyNumber=0, likeNumber=67, createdTime=2018-04-12, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01ce13390346, moduleTitle=Int J Cancer：铂抵抗性卵巢癌模型中，FASN抑制剂对其产生的生长和代谢影响研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01ce13390346)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737583, encodeId=081d1e375839d, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Cell Death Dis：α-硫辛酸对顺铂诱导的耳毒性的保护和治疗效应评估, objectType=article, longId=146471, objectId=07161464e1b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07161464e1b6, replyNumber=0, likeNumber=65, createdTime=2019-04-04, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07161464e1b6, moduleTitle=Cell Death Dis：α-硫辛酸对顺铂诱导的耳毒性的保护和治疗效应评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07161464e1b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737575, encodeId=3ccb1e3757599, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=CLIN CANCER RES：Guadecitabine联合卡铂治疗铂类耐药复发卵巢癌, objectType=article, longId=139686, objectId=ff45139686f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff45139686f9, replyNumber=0, likeNumber=51, createdTime=2019-04-01, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff45139686f9, moduleTitle=CLIN CANCER RES：Guadecitabine联合卡铂治疗铂类耐药复发卵巢癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff45139686f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737581, encodeId=196b1e37581d5, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JCO：顺铂不能延长老年非小细胞肺癌患者总生存, objectType=article, longId=144994, objectId=8a2914499419, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a2914499419, replyNumber=0, likeNumber=67, createdTime=2018-09-26, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a2914499419, moduleTitle=JCO：顺铂不能延长老年非小细胞肺癌患者总生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a2914499419)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

铂

2020-05-29

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

J Gastroenterology：吉西他滨联合顺铂作为一线化疗的晚期胆道癌患者治疗结果的预测因子分析

2019-08-22

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

ANN ONCOL：直肠癌患者年龄对奥沙利铂有效性的影响

2019-06-16

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

ANN ONCOL：蛋白结合型紫杉醇联合卡铂或吉西他滨治疗转移性三阴性乳腺癌

2019-04-02

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

CLIN CANCER RES：新辅助卡铂和多西他赛治疗的三阴性乳腺癌患者的病理缓解情况

2018-09-10

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet Oncol：多西紫杉醇、顺铂和氟尿嘧啶联合化疗用于晚期肛门鳞状细胞癌

2018-12-01

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JCO：新辅助吉西他滨联合顺铂治疗肌层浸润膀胱癌

2018-11-28

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Clin Cancer Res：顺铂诱导毒性的遗传和可修饰风险因素分析

2019-06-06

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JCO：卡铂-紫杉醇 vs 卡铂-紫杉醇-曲妥珠单抗治疗子宫浆液性癌

2018-04-08

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Sci Rep：肿瘤浸润性淋巴细胞对患有转移性尿路上皮癌且接受铂化疗患者的预后影响

2018-07-13

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Nat Med：“靶向化疗”成为可能—卡铂用于治疗BRCA1/2突变及BRCAness表型三阴性乳腺癌的III期TNT研究

2019-04-15

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Acta Oncol：睾丸癌幸存者铂化疗前后听力损失研究

2018-12-31

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

J Gastroenterology：吉西他滨联合顺铂作为一线化疗的晚期胆道癌患者预后风险评估

2018-10-15

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

BJC：S-1加顺铂联合同步放疗治疗局部晚期不可切除的非小细胞肺癌

2019-03-03

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

CLIN CANCER RES：AZD1775联合新辅助多西他赛和顺铂治疗头颈部鳞状细胞癌

2019-03-06

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet Oncol：卡波铂+ veliparib对三阴性乳腺癌高危患者新标准化疗效果的影响

2018-10-05

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Prostate Cancer P D：转移性前列腺癌中的铂敏感性分析

2018-06-16

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Int J Cancer：铂抵抗性卵巢癌模型中，FASN抑制剂对其产生的生长和代谢影响研究

2018-04-12

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Cell Death Dis：α-硫辛酸对顺铂诱导的耳毒性的保护和治疗效应评估

2019-04-04

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

CLIN CANCER RES：Guadecitabine联合卡铂治疗铂类耐药复发卵巢癌

2019-04-01

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JCO：顺铂不能延长老年非小细胞肺癌患者总生存

2018-09-26

科室
- - 订阅+
  - 更多科室
工具
服务